Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessMarkets

Cadila Health gains 3% on Establishment Inspection Report from USFDA

The topical manufacturing facility had completed the USFDA audit during December 16-20, 2019.

February 10, 2020 / 04:21 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Cadila Healthcare gained 2.6 percent intraday on February 10 after receiving Establishment Inspection Report from the US health regulator for Ahmedabad unit.

The topical manufacturing facility had completed the USFDA audit during December 16-20, 2019.

After the inspection, the plant received zero 483 observations.

Hence, the facility located at Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA signifying successful closure of the audit, Cadila said in its BSE filing.

The stock was quoting at Rs 276.60, up Rs 1.30, or 0.47 percent on the BSE at 1518 hours IST.

Moneycontrol News
first published: Feb 10, 2020 04:21 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347